A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
Clinical trial NCT02009397 · COMPLETED
Trial details
- NCT number
- NCT02009397
- Sponsor
- University of Louisville
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.